reperfusion injury, myocardial

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myocardial Infarction, Reperfusion Injury, Myocardial Trial in Uxbridge (Transcoronary cooling and dilution, Standard of care)

Recruiting
  • Myocardial Infarction
  • Reperfusion Injury, Myocardial
  • Transcoronary cooling and dilution
  • Standard of care
  • Uxbridge, United Kingdom
    Harefield Hospital
Nov 7, 2023

Reperfusion Injury, Myocardial Trial in Jakarta Pusat (Colchicine, Placebo (lactose))

Enrolling by invitation
  • Reperfusion Injury, Myocardial
  • Jakarta Pusat, Jakarta, Indonesia
    Fakultas Kedokteran Universitas Indonesia
Feb 8, 2023

Acute Myocardial Infarction, Ischemia-reperfusion Injury, Reperfusion Injury, Myocardial Trial in Santiago de Chile (Antioxidant

Recruiting
  • Acute Myocardial Infarction
  • +4 more
  • Antioxidant formula
  • Dextrose 5% in water
  • Santiago de Chile, Chile
    University of Chile
Jan 17, 2022

Coronary Artery Disease, Coronary Artery Bypass, Cardiopulmonary Bypass Trial (Nitric Oxide, Standard CPB)

Completed
  • Coronary Artery Disease
  • +4 more
  • Nitric Oxide
  • Standard CPB
  • (no location specified)
Jul 1, 2019

CMR to Assess Severity and Prognosis of Reperfusion Injury After

Unknown status
  • STEMI - ST Elevation Myocardial Infarction
  • Reperfusion Injury, Myocardial
  • Treg levels and CMR results
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Jun 25, 2019

Reperfusion Injury, Myocardial Trial (Empagliflozin, )

Unknown status
  • Reperfusion Injury, Myocardial
  • (no location specified)
Jul 17, 2018

Reperfusion Injury, Myocardial Trial in Beijing (melatonin (Helsinn Chemical Co, Biasca, Switzerland), Placebos)

Unknown status
  • Reperfusion Injury, Myocardial
  • melatonin (Helsinn Chemical Co, Biasca, Switzerland)
  • Placebos
  • Beijing, Beijing, China
    PLA General Hospital
Oct 4, 2017